EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Dimopoulos, Christina
Hung, Kenneth
Proctor, Deborah
Ruggiero, Eilzabeth
Al-Bawardy, Badr
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
23
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [1] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S19 - S20
  • [2] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth W.
    Proctor, Deborah D.
    Ruggiero, Elizabeth
    Al-Bawardy, Badr
    GASTROENTEROLOGY, 2020, 158 (06) : S675 - S675
  • [3] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fleisher, Mark
    Marsal, Jan
    Lee, Scott D.
    Frado, Laura E.
    Parian, Alyssa
    Korelitz, Burton I.
    Feagan, Brian G.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (04) : 825 - 833
  • [4] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Hanzel, Jurij
    Ma, Christopher
    Vande Casteele, Niels
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    DRUGS, 2021, 81 (03) : 333 - 347
  • [5] Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 333 - 347
  • [6] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Mark Fleisher
    Jan Marsal
    Scott D. Lee
    Laura E. Frado
    Alyssa Parian
    Burton I. Korelitz
    Brian G. Feagan
    Digestive Diseases and Sciences, 2018, 63 : 825 - 833
  • [7] Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
    Jurij Hanzel
    Christopher Ma
    Niels Vande Casteele
    Reena Khanna
    Vipul Jairath
    Brian G. Feagan
    Drugs, 2021, 81 : 1697 - 1697
  • [8] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [9] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [10] VEDOLIZUMAB INDUCES DE NOVO EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Kim, Su Bin
    Diaz, Liege I.
    Calmet, Fernando
    Quintero, Maria A.
    Schwartz, Ingrid
    Abreu, Maria T.
    GASTROENTEROLOGY, 2018, 154 (06) : S360 - S360
12345